The potential impact of USP 797 and what the JCAAI is doing about it.
Nathan
Robert
R
D000485:Allergens / Q000276:immunology*; D001207:Asepsis / Q000592:standards*; D004339:Drug Compounding / Q000592:standards; D004340:Drug Contamination / Q000331:legislation & jurisprudence / Q000517:prevention & control*; D004356:Drug Storage / Q000592:standards; D004335:Drug and Narcotic Control; D019983:Guideline Adherence; D017408:Guidelines as Topic; D006801:Humans; D007885:Legislation, Pharmacy; D010602:Pharmacopoeias as Topic; D011786:Quality Control; D014481:United States; D014612:Vaccines / Q000592:standards*
D000485:Allergens; D014612:Vaccines